Trial Profile
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms HIROP-ACS
- 11 Nov 2013 New trial record